8-K: Imunon Announces CFO Retirement and Appointment of Successor

Imunon, Inc. has announced the retirement of its Chief Financial Officer, Jeffrey Church, and the appointment of David Gaiero as his successor, effective June 1, 2024.

Summary

• Imunon's Chief Financial Officer, Jeffrey Church, will retire from all positions with the company effective June 1, 2024.
• Mr. Church will transition to a consulting role with the company for seven months, until December 31, 2024, with a monthly retainer of $10,000 plus $250 per hour for services exceeding 40 hours per month.
• Mr. Church will receive a retirement bonus of $428,615.00, any accrued but unpaid salary, and reimbursement for business expenses.
• He will also be eligible for a portion of his 2023 performance-based bonus and a pro-rated bonus for 2024.
• David Gaiero has been appointed as the new Chief Financial Officer, effective June 1, 2024.
• Mr. Gaiero will be provided by Monomoy Advisors, LLC, a financial advisory services firm, and Imunon will pay Monomoy $35,000 per month for his services.

Sentiment

Score: 7

Explanation: The document outlines a planned executive transition, which is generally neutral. The company has taken steps to ensure a smooth handover, which is positive. However, the costs associated with the transition are a slight negative.

Positives

• A smooth transition is planned with the outgoing CFO providing consulting services for seven months.
• The company has quickly secured a new CFO with relevant experience.
• The consulting agreement with the outgoing CFO ensures continuity and knowledge transfer.

Negatives

• The company is incurring a significant one-time expense of $428,615 for the retiring CFO's bonus.
• The company will be paying $35,000 per month for the new CFO's services through a consulting firm.

Risks

• There is a risk of disruption during the transition period between CFOs.
• The company is reliant on a consulting firm for its CFO services, which may not be as integrated as a direct employee.
• The cost of the new CFO's services is higher than a typical salary, at $35,000 per month.

Future Outlook

The company anticipates a smooth transition with the outgoing CFO providing consulting services and the new CFO taking over on June 1, 2024.

Management Comments

• Jeffrey Church informed Imunon, Inc. of his intent to retire from all positions with the Company.
• Mr. Church and the Company agreed that he will transition to a consulting role with the Company.
• The Company appointed David Gaiero to serve as the Company's new Chief Financial Officer.

Industry Context

The change in CFO is a common occurrence in the corporate world, and Imunon's approach of using a consulting firm for the new CFO is not unusual, especially for smaller companies or during transition periods. The use of a consulting agreement for the outgoing CFO is also a common practice to ensure a smooth transition.

Comparison to Industry Standards

• The use of a consulting firm for CFO services is common in the biotech industry, especially for companies of Imunon's size and stage.
• The compensation structure for the outgoing CFO, including a retirement bonus and consulting fees, is within industry norms for executive departures.
• The monthly fee of $35,000 for the new CFO's services is comparable to rates charged by financial advisory firms for interim CFO roles.

Management Changes

Stakeholder Impact

• Shareholders may react to the news of a CFO change, but the planned transition should mitigate concerns.
• Employees will experience a change in leadership in the finance department.
• The company's financial partners will need to establish a working relationship with the new CFO.

Next Steps

• Jeffrey Church will transition to a consulting role until December 31, 2024.
• David Gaiero will assume the role of CFO on June 1, 2024.
• The company will continue to operate under the new financial leadership.

Key Dates

Keywords

Chief Financial Officer, CFO, retirement, appointment, consulting, financial officer, Monomoy Advisors, executive transition